{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T08:50:55Z","timestamp":1758444655915,"version":"3.44.0"},"reference-count":30,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T00:00:00Z","timestamp":1710806400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002129","name":"Heart Foundation","doi-asserted-by":"publisher","award":["CVON2015-21"],"award-info":[{"award-number":["CVON2015-21"]}],"id":[{"id":"10.13039\/100002129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"accepted":{"date-parts":[[2024,1,23]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>We assessed the prevalence and diagnostic value of ECG abnormalities for cardiomyopathy surveillance in childhood cancer survivors.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this cross-sectional study, 1381 survivors (\u22655\u2009years) from the Dutch Childhood Cancer Survivor Study part 2 and 272 siblings underwent a long-term follow-up ECG and echocardiography. We compared ECG abnormality prevalences using the Minnesota Code between survivors and siblings, and within biplane left ventricular ejection fraction (LVEF) categories. Among 880 survivors who received anthracycline, mitoxantrone or heart radiotherapy, logistic regression models using least absolute shrinkage and selection operator identified ECG abnormalities associated with three abnormal LVEF categories (&lt;52% in male\/&lt;54% in female, &lt;50%\u2009and &lt;45%). We assessed the overall contribution of these ECG abnormalities to clinical regression models predicting abnormal LVEF, assuming an absence of systolic dysfunction with a &lt;1% threshold probability.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>16% of survivors (52% female, mean age 34.7 years) and 14% of siblings had major ECG abnormalities. ECG abnormalities increased with decreasing LVEF. Integrating selected ECG data into the baseline model significantly improved prediction of sex-specific abnormal LVEF (c-statistic 0.66 vs 0.71), LVEF &lt;50% (0.66 vs 0.76) and LVEF &lt;45% (0.80 vs 0.86). While no survivor met the preset probability threshold in the first two models, the third model used five ECG variables to predict LVEF &lt;45%\u2009and was applicable for ruling out (sensitivity 93%, specificity 56%, negative predictive value 99.6%). Calibration and internal validation tests performed well.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>A clinical prediction model with ECG data (left bundle branch block, left atrial enlargement, left heart axis, Cornell\u2019s criteria for left ventricular hypertrophy and heart rate) may aid in ruling out LVEF &lt;45%.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/heartjnl-2023-323474","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T13:23:13Z","timestamp":1710854593000},"page":"726-734","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors"],"prefix":"10.1136","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2694-8783","authenticated-orcid":false,"given":"Esm\u00e9e C","family":"de Baat","sequence":"first","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9853-7257","authenticated-orcid":false,"given":"Remy","family":"Merkx","sequence":"additional","affiliation":[{"name":"Medical Imaging, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan M","family":"Leerink","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1515-9623","authenticated-orcid":false,"given":"Coen","family":"Boerhout","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heleen J H","family":"van der Pal","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira C","family":"van Dalen","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Loonen","sequence":"additional","affiliation":[{"name":"Pediatric Hematology and Oncology, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorine","family":"Bresters","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"Leiden University Medical Center, Willem Alexander Children's Hospital, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eline","family":"van Dulmen-den Broeder","sequence":"additional","affiliation":[{"name":"Amsterdam University Medical Centres, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margriet","family":"van der Heiden-van der Loo","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marry M","family":"van den Heuvel","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"Department of Pediatric Oncology, Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith L","family":"Kok","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marloes","family":"Louwerens","sequence":"additional","affiliation":[{"name":"Medical Oncologist, Department of Internal Medicine, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian J C M M","family":"Neggers","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecline M","family":"Ronckers","sequence":"additional","affiliation":[{"name":"University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jop C","family":"Teepen","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wim J E","family":"Tissing","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"University Medical Centre Groningen, Beatrix Children's Hospital, Groningen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrica C","family":"de Vries","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"Erasmus Medical Center, Rotterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Livia","family":"Kapusta","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Tel Aviv University, Tel Aviv, Israel"},{"name":"Department of Paediatrics, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leontien C M","family":"Kremer","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"},{"name":"Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelies M C","family":"Mavinkurve-Groothuis","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter E M","family":"Kok","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Amsterdam UMC, Amsterdam, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8930-3160","authenticated-orcid":false,"given":"Elizabeth A M","family":"Feijen","sequence":"additional","affiliation":[{"name":"Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,3,19]]},"reference":[{"key":"2025092001064017000_110.10.726.1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaccao.2020.08.006","article-title":"Cardiac disease in childhood cancer survivors - risk prediction, prevention, and surveillance: JACC Cardiooncology state-of-the-art review","volume":"2","author":"Leerink","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2025092001064017000_110.10.726.2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(23)00012-8"},{"key":"2025092001064017000_110.10.726.3","unstructured":"Group CsO . Long-term follow-up guidelines for survivors of childhood, adolescent and young adult cancers, . 2013 Available: www.survivorshipguidelines.org"},{"key":"2025092001064017000_110.10.726.4","doi-asserted-by":"crossref","unstructured":"Pourier MS , Mavinkurve-Groothuis AMC , Loonen J , et al . Is screening for abnormal ECG patterns justified in long-term follow-up of childhood cancer survivors treated with anthracyclines Pediatr Blood Cancer 2017;64. doi:10.1002\/pbc.26243","DOI":"10.1002\/pbc.26243"},{"key":"2025092001064017000_110.10.726.5","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29720","article-title":"Electrocardiographic abnormalities in childhood cancer survivors treated with cardiotoxic therapy: a systematic review pediatric blood & cancer","volume":"69","author":"de Baat","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"2025092001064017000_110.10.726.6","doi-asserted-by":"crossref","unstructured":"Prineas RJ , Crow RS , Zhang Z-M . The Minnesota Code Manual of Electrocardiographic Findings. London, 2010. doi:10.1007\/978-1-84882-778-3","DOI":"10.1007\/978-1-84882-778-3"},{"key":"2025092001064017000_110.10.726.7","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.80.6.570"},{"key":"2025092001064017000_110.10.726.8","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.434"},{"key":"2025092001064017000_110.10.726.9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006023","article-title":"Electrocardiographic predictors of heart failure with reduced versus preserved ejection fraction: the multi-ethnic study of atherosclerosis","volume":"6","author":"O\u2019Neal","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2025092001064017000_110.10.726.10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ahj.2017.03.023","article-title":"Electrocardiographic abnormalities and mortality in aging survivors of childhood cancer: a report from the St Jude lifetime cohort study","volume":"189","author":"Mulrooney","year":"2017","journal-title":"Am Heart J"},{"key":"2025092001064017000_110.10.726.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7229.220"},{"key":"2025092001064017000_110.10.726.12","first-page":"48","article-title":"Assessing the diagnostic test accuracy of natriuretic peptides and ECG in the diagnosis of left ventricular systolic dysfunction: a systematic review and meta-analysis","volume":"56","author":"Davenport","year":"2006","journal-title":"Br J Gen Pract"},{"key":"2025092001064017000_110.10.726.13","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"2025092001064017000_110.10.726.14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ahj.2019.10.010","article-title":"Diagnostic tools for early detection of cardiac dysfunction in childhood cancer survivors: methodological aspects of the dutch late effects after childhood cancer (LATER) cardiology study","volume":"219","author":"Leerink","year":"2020","journal-title":"Am Heart J"},{"key":"2025092001064017000_110.10.726.15","doi-asserted-by":"crossref","unstructured":"Feijen EAM , Teepen JC , van Dulmen\u2010den Broeder E , et al . Clinical evaluation of late outcomes in dutch childhood cancer survivors: methodology of the DCCSS LATER 2 study. Pediatric Blood & Cancer 2023;70. doi:10.1002\/pbc.30212 Available: https:\/\/onlinelibrary.wiley.com\/toc\/15455017\/70\/5","DOI":"10.1002\/pbc.30212"},{"key":"2025092001064017000_110.10.726.16","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamaoncol.2018.6634","article-title":"Derivation of anthracycline and anthraquinone equivalence ratios to doxorubicin for late-onset cardiotoxicity","volume":"5","author":"Feijen","year":"2019","journal-title":"JAMA Oncol"},{"key":"2025092001064017000_110.10.726.17","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24679"},{"key":"2025092001064017000_110.10.726.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2015.05.033"},{"key":"2025092001064017000_110.10.726.19","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.115.003116","article-title":"Predicting heart failure with preserved and reduced ejection fraction: the International collaboration on heart failure subtypes","volume":"9","author":"Ho","year":"2016","journal-title":"Circ Heart Fail"},{"key":"2025092001064017000_110.10.726.20","doi-asserted-by":"crossref","unstructured":"Markman TM , Ruble K , Loeb D , et al . Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancy. Pediatric Blood & Cancer 2017;64. doi:10.1002\/pbc.26556 Available: https:\/\/onlinelibrary.wiley.com\/toc\/15455017\/64\/11","DOI":"10.1002\/pbc.26556"},{"key":"2025092001064017000_110.10.726.21","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/echo.15081","article-title":"Echocardiography protocol for early detection of cardiac dysfunction in childhood cancer survivors in the multicenter DCCSS LATER 2 CARD study: design, feasibility, and reproducibility","volume":"38","author":"Merkx","year":"2021","journal-title":"Echocardiography"},{"key":"2025092001064017000_110.10.726.22","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O"},{"key":"2025092001064017000_110.10.726.23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32520-5"},{"key":"2025092001064017000_110.10.726.24","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0424"},{"key":"2025092001064017000_110.10.726.25","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.33860"},{"key":"2025092001064017000_110.10.726.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.071"},{"key":"2025092001064017000_110.10.726.27","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.tcm.2018.09.004","article-title":"Silent myocardial infarction and risk of heart failure: current evidence and gaps in knowledge","volume":"29","author":"Soliman","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"2025092001064017000_110.10.726.28","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1200\/CCI.20.00176","article-title":"Artificial intelligence-assisted prediction of late-onset cardiomyopathy among childhood cancer survivors","volume":"5","author":"G\u00fcnt\u00fcrk\u00fcn","year":"2021","journal-title":"JCO Clin Cancer Inform"},{"key":"2025092001064017000_110.10.726.29","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jaccao.2020.11.013","article-title":"Refining the 10-year prediction of left ventricular systolic dysfunction in long-term survivors of childhood cancer","volume":"3","author":"Leerink","year":"2021","journal-title":"JACC CardioOncol"},{"key":"2025092001064017000_110.10.726.30","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2019"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2023-323474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T08:06:50Z","timestamp":1758355610000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2023-323474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,19]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2024,4,25]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/heartjnl-2023-323474"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2023-323474","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"type":"print","value":"1355-6037"},{"type":"electronic","value":"1468-201X"}],"subject":[],"published":{"date-parts":[[2024,3,19]]}}}